Stock data
Collegium Pharmaceutical, Inc. (COLL)
Collegium Pharmaceutical, Inc. (COLL) reported revenue of US$780.57M and net income of US$62.87M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$780.57M | US$463.26M | US$179.64M | US$62.87M | — |
| 2024 | US$631.45M | US$377.34M | US$169.90M | US$69.19M | — |
| 2023 | US$566.77M | US$326.17M | US$166.96M | US$48.16M | — |
| 2022 | US$463.93M | US$209.49M | US$33.32M | -US$25.00M | — |
| 2021 | US$276.87M | US$150.62M | US$17.63M | US$71.52M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$199.88M | -US$15.05M | — |
| 2026-03-31 | US$193.52M | US$14.50M | — |
| 2025-12-31 | US$205.45M | US$16.96M | — |
| 2025-09-30 | US$209.36M | US$31.51M | — |
| 2025-06-30 | US$188.00M | US$11.98M | — |
| 2025-03-31 | US$177.76M | US$2.42M | — |
| 2024-12-31 | US$181.95M | US$12.54M | — |
| 2024-09-30 | US$159.30M | US$9.34M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.